Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody (GB221) for Injection (Q76980680)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody (GB221) for Injection |
clinical trial |
Statements
A Randomized, Double-blind, Multi-center Phase Ⅲ Clinical Study to Evaluate the Recombinant Anti-HER2 Humanized Monoclonal Antibody or Placebo in Combination With Capecitabine for the Treatment of HER-2-positive Advanced Breast Cancer (English)
0 references
24 November 2016
0 references
July 2020
0 references
336
0 references
18 year
0 references
70 year
0 references